Pharmacyclics LLC v. Acerta Pharma B.V. et al
Plaintiff: Pharmacyclics LLC
Defendant: Acerta Pharma LLC, Acerta Pharma B.V. and AstraZeneca Pharmaceuticals LP
Case Number: 1:2017cv01582
Filed: November 3, 2017
Court: US District Court for the District of Delaware
Office: Wilmington Office
County: New Castle
Presiding Judge: Vacant Judgeship (2017)
Referring Judge: Richard G Andrews
2 Judge: Mary Pat Thynge
Nature of Suit: Patent
Cause of Action: 35 U.S.C. § 271
Jury Demanded By: Plaintiff
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on August 7, 2019. A more recent docket listing may be available from PACER.

Date Filed Document Text
April 2, 2019 Filing 135 NOTICE OF SERVICE of Pharmacyclics LLC's Reply Claim Construction Brief filed by Pharmacyclics LLC.(Tigan, Jeremy)
April 1, 2019 Filing 134 NOTICE of Amended Third Party Subpoena to Orion Jankowski, by AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 4/1/2019 (nms).
April 1, 2019 Filing 133 NOTICE of Amended Third Party Subpoena to Kyle Elrod by AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 4/1/2019 (nms).
April 1, 2019 Filing 132 NOTICE of Amended Third Party Subpoena to Douglas A. Jeffrey, by AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 4/1/2019 (nms).
March 25, 2019 Filing 131 NOTICE to Take Deposition of Eric V. Anslyn, Ph.D. on March 28, 2019 filed by Pharmacyclics LLC.(Tigan, Jeremy)
March 22, 2019 Pro Hac Vice Attorney Robert Smyth for Acerta Pharma B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-00581-RGA, 1:17-cv-01582-RGA(ceg)
March 20, 2019 Filing 130 NOTICE OF SERVICE of 1) Defendants Answering Claim Construction Brief; and 2) Declaration of Eric V. Anslyn, Ph.D. in Support of Defendants Answering Claim Construction Brief filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam)
March 19, 2019 Filing 129 MOTION for Pro Hac Vice Appearance of Attorney Robert Smyth, PhD. - filed by Acerta Pharma B.V., Acerta Pharma LLC. (Gorman, John)
March 19, 2019 Opinion or Order SO ORDERED, re #129 MOTION for Pro Hac Vice Appearance of Attorney Robert Smyth, PhD., filed by Acerta Pharma LLC, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 3/19/2019. (nms)
March 15, 2019 Filing 128 NOTICE OF SERVICE of Non-Party Dr. Maria Fardis's Supplemental Responses and Objections to Plaintiff's Subpoena re #121 Notice of Service filed by Acerta Pharma B.V., Acerta Pharma LLC.(Dudash, Amy)
March 7, 2019 Filing 127 NOTICE to Take Deposition of Eric N. Jacobsen, Ph.D. on March 13, 2019 beginning at 9:00 a.m. filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam)
March 6, 2019 Filing 126 NOTICE OF SERVICE of Non-Party Paula Franson Banniga's Supplemental Responses and Objections to Plaintiff's Document Subpoena, filed by Acerta Pharma B.V., Acerta Pharma LLC.(Dudash, Amy) Modified on 3/7/2019 (nms).
March 5, 2019 Filing 125 NOTICE OF SERVICE of Deposition Subpoenas filed by AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibits 1-8)(Poff, Adam) Modified on 3/6/2019 (nms).
March 5, 2019 Filing 124 NOTICE OF SERVICE of Defendants' Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam)
February 22, 2019 Filing 123 NOTICE OF SERVICE of Pharmacyclics LLC's Opening Claim Construction Brief filed by Pharmacyclics LLC.(Tigan, Jeremy)
February 21, 2019 Filing 122 NOTICE OF SERVICE of Non-Party Paula Franson Banninga's Objections and Responses to Plaintiff Pharmacyclics LLC's Document Subpoena, filed by Acerta Pharma B.V., Acerta Pharma LLC.(Dudash, Amy) Modified on 2/21/2019 (nms).
February 20, 2019 Filing 121 NOTICE OF SERVICE of Non-Party Maria Fardis's Responses and Objections to Plaintiff Pharmacyclics LLC's Document Subpoena, filed by Acerta Pharma B.V., Acerta Pharma LLC.(Dudash, Amy) Modified on 2/21/2019 (nms).
February 19, 2019 Filing 120 NOTICE OF SERVICE of Objections of Non-Parties Stephen Chan and Jesse McGreivy to Document Subpoenas, filed by Acerta Pharma B.V., Acerta Pharma LLC.(Dudash, Amy) Modified on 2/21/2019 (nms).
February 12, 2019 Opinion or Order SO ORDERED, re #117 STIPULATION TO EXTEND TIME to Submit Joint Claim Chart to February 11, 2019. Signed by Judge Richard G. Andrews on 2/11/2019. (nms)
February 12, 2019 Opinion or Order SO ORDERED, re #118 STIPULATION TO EXTEND TIME for Claim Construction Briefing (*Reset Deadlines: Joint Claim Construction Brief due by 4/19/2019). Signed by Judge Richard G. Andrews on 2/12/2019. (nms)
February 12, 2019 Pro Hac Vice Attorney James Kirkpatrick for AstraZeneca Pharmaceuticals LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp)
February 11, 2019 Filing 119 Joint Claim Construction Chart, by Pharmacyclics LLC. (Attachments: #1 Exhibit 1-3)(Tigan, Jeremy) Modified on 2/12/2019 (nms).
February 11, 2019 Filing 118 STIPULATION TO EXTEND TIME for Claim Construction Briefing to Various Dates - filed by Pharmacyclics LLC. (Tigan, Jeremy)
February 8, 2019 Filing 117 STIPULATION TO EXTEND TIME to Submit Joint Claim Chart to February 11, 2019 - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam)
February 8, 2019 Filing 116 NOTICE of Third Party Subpoena to Michelle Xia by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms).
February 8, 2019 Filing 115 NOTICE of Third Party Subpoena to Erik J. Verner by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms).
February 8, 2019 Filing 114 NOTICE of Third Party Subpoena to Robert Rydzewski by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms).
February 8, 2019 Filing 113 NOTICE of Third Party Subpoena to Tarak Mody by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms).
February 8, 2019 Filing 112 NOTICE of Third Party Subpoena to Richard Miller by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms).
February 8, 2019 Filing 111 NOTICE of Third Party Subpoena to Tania Mahajan by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms).
February 8, 2019 Filing 110 NOTICE of Third Party Subpoena to David J. Loury by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms).
February 8, 2019 Filing 109 NOTICE of Third Party Subpoena to James Janc by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms).
February 8, 2019 Filing 108 NOTICE of Third Party Subpoena to Orion Jankowski by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms).
February 8, 2019 Filing 107 NOTICE of Third Party Subpoena to Leslie Holsinger by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms).
February 8, 2019 Filing 106 NOTICE of Third Party Subpoena to Bernie Hirschbein by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1 - Subpoena)(Poff, Adam)
February 8, 2019 Filing 105 NOTICE of Third Party Subpoena to Michael Green by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms).
February 8, 2019 Filing 104 NOTICE of Third Party Subpoena to Kyle Elrod by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms).
February 8, 2019 Filing 103 NOTICE of Third Party Subpoena to Wei Chen by AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms).
February 8, 2019 Filing 102 NOTICE of Third Party Subpoena to Kareem Chehade by AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/8/2019 (nms).
February 8, 2019 Filing 101 NOTICE of Third Party Subpoena to Joseph J. Buggy by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 2/8/2019 (nms).
February 7, 2019 Filing 100 Amended NOTICE of Subpoena to Paula Franson by Pharmacyclics LLC (Tigan, Jeremy)
February 6, 2019 Opinion or Order SO ORDERED, re #99 STIPULATION TO EXTEND TIME to Submit the Joint Claim Chart to February 8, 2019. Signed by Judge Richard G. Andrews on 2/5/2019. (nms)
February 5, 2019 Filing 99 STIPULATION TO EXTEND TIME to Submit the Joint Claim Chart to February 8, 2019 - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam)
February 5, 2019 Opinion or Order SO ORDERED, re #98 MOTION for Pro Hac Vice Appearance of Attorney James Kirkpatrick, filed by AstraZeneca Pharmaceuticals LP. Signed by Judge Richard G. Andrews on 2/5/2019. (nms)
February 4, 2019 Filing 98 MOTION for Pro Hac Vice Appearance of Attorney James Kirkpatrick - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam)
February 1, 2019 Filing 97 NOTICE of Subpoenas, by Pharmacyclics LLC. (Tigan, Jeremy) Modified on 2/1/2019 (nms).
January 25, 2019 Filing 96 NOTICE OF SERVICE of Pharmacyclics LLC's Responses and Objections to Defendants First Joint Set of Interrogatories (Nos. 7-21) filed by Pharmacyclics LLC.(Tigan, Jeremy)
January 25, 2019 Pro Hac Vice Attorney Michael A. Morin for Pharmacyclics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak)
January 24, 2019 Filing 95 NOTICE OF SERVICE of Defendants' Amended Initial Disclosures filed by AstraZeneca Pharmaceuticals LP.(Kraman, Pilar)
January 24, 2019 Filing 94 NOTICE OF SERVICE of Defendants' Disclosure of Proposed Claim Terms for Construction and Proposed Constructions filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam)
January 23, 2019 Filing 93 NOTICE OF SERVICE of Plaintiff's Proposed Claim Terms for Construction filed by Pharmacyclics LLC.(Tigan, Jeremy)
January 16, 2019 Filing 92 NOTICE of Third Party Subpoena to Heleen Scheerens by AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit 1)(Poff, Adam) Modified on 1/17/2019 (nms).
January 14, 2019 Opinion or Order SO ORDERED, re #91 STIPULATION and Proposed Order. Signed by Judge Richard G. Andrews on 1/11/2019. (nms)
January 11, 2019 Filing 91 STIPULATION and Proposed Order - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam) Modified on 1/11/2019 (nms).
January 8, 2019 Filing 90 NOTICE of Third Party Subpoena of Zhengying Pan, by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Kraman, Pilar) Modified on 1/9/2019 (nms).
January 8, 2019 Filing 89 NOTICE of Third Party Subpoena of Paul G. Grothaus, by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Kraman, Pilar) Modified on 1/9/2019 (nms).
January 8, 2019 Filing 88 NOTICE of Third Party Subpoena of Leland C. Burrill, by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Kraman, Pilar) Modified on 1/9/2019 (nms).
January 8, 2019 Filing 87 NOTICE of Third Party Subpoena of Keana C.K. Scott, by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Kraman, Pilar) Modified on 1/9/2019 (nms).
January 8, 2019 Filing 86 NOTICE of Third Party Subpoena of James T. Palmer, by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Kraman, Pilar) Modified on 1/9/2019 (nms).
January 8, 2019 Filing 85 NOTICE of Third Party Subpoena on Douglas A. Jeffery, by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit 1)(Kraman, Pilar) Modified on 1/9/2019 (nms).
January 8, 2019 Filing 84 NOTICE of Third Party Subpoena on Brian E. Schultz, by AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit 1)(Kraman, Pilar) Modified on 1/9/2019 (nms).
December 21, 2018 Filing 83 NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's Second Set of Requests for Production (Nos. 107-120) filed by AstraZeneca Pharmaceuticals LP.(Kraman, Pilar)
December 12, 2018 Filing 82 NOTICE OF SERVICE of Pharmacyclics LLC's First Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and Pharmacyclics LLC's First Amended Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Pharmacyclics LLC.(Tigan, Jeremy)
December 5, 2018 Filing 81 NOTICE OF SERVICE of Defendants First Joint Set of Interrogatories to Pharmacyclics LLC filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam)
November 26, 2018 Filing 80 NOTICE OF SERVICE of Defendants Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-20) filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam)
November 21, 2018 Filing 79 NOTICE OF SERVICE of Pharmacyclics LLC's Second Set of Requests to Defendants for the Production of Documents and Things (Nos. 107-120) filed by Pharmacyclics LLC.(Tigan, Jeremy)
November 20, 2018 Opinion or Order Filing 78 ORDER Setting Mediation Conference: A Telephone Conference is set for 3/4/2019 at 10:45 AM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 11/20/2018. Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA(dlb)
October 26, 2018 Pro Hac Vice Attorney Lauren Sharkey for Pharmacyclics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
October 24, 2018 Pro Hac Vice Attorney Brenda L. Danek for Pharmacyclics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
October 24, 2018 Pro Hac Vice Attorney Lesley M. Hamming for Pharmacyclics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
October 23, 2018 Opinion or Order Filing 77 ORDER Setting Mediation Conference: A Telephone Conference is set for 11/19/2018 at 10:15 AM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 10/23/2018. Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA(dlb)
October 22, 2018 CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA(cak)
October 19, 2018 Filing 76 NOTICE OF SERVICE of Pharmacyclics LLC's Responses and Objections to Defendant AstraZeneca Pharmaceuticals LP's First Set of Interrogatories (Nos. 1-6) filed by Pharmacyclics LLC.(Tigan, Jeremy)
October 17, 2018 Filing 75 Joint Status Report, by Pharmacyclics LLC. (Tigan, Jeremy) Modified on 10/18/2018 (nms).
October 5, 2018 Opinion or Order Filing 74 ORAL ORDER: In light of the reassignment of this matter the Court will adopt the Scheduling Order filed at D.I. #29 with the following modifications:(1) The case is now referred to a Magistrate Judge for the purpose of exploring ADR; (2) Should counsel find they are unable to resolve a discovery matter or other matters the parties involved shall contact chambers at (302) 573-4581; (3) The Status Conference set for November 1, 2018, is now CANCELLED. Should the parties wish to have a future conference set they will advise the Court accordingly; (4) The jury trial will be five days in length. Ordered by Judge Richard G. Andrews on 10/5/2018. (nms)
October 3, 2018 Opinion or Order Filing 73 ORDER: The motions to consolidate (D.I. 49 in C.A. 17-1582-RGA; D.I. 12 in C.A. 18-581-RGA) and the motion for leave to amend answer, etc. (D.I. 56 in C.A. 17-1582-RGA) are DENIED. Further, the scheduling order (D.I. 29 in C.A. 17-1582-RGA) is MODIFIED to reflect a jury trial will be five days long. Signed by Judge Richard G. Andrews on 10/3/2018. Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA(nms)
October 1, 2018 Filing 72 NOTICE OF SERVICE of Pharmacyclics LLC's First Set of Interrogatories to Defendants (Nos. 1-20) filed by Pharmacyclics LLC.(Tigan, Jeremy)
September 19, 2018 Filing 71 NOTICE OF SERVICE of Defendant AstraZeneca Pharmaceuticals LP's First Set of Interrogatories to Pharmacyclics filed by AstraZeneca Pharmaceuticals LP.(Kraman, Pilar)
September 6, 2018 Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA (rjb)
August 27, 2018 Filing 70 NOTICE of Subpoena Duces Tecum to Peter R. Young by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit A, #2 Certificate of Service)(Kraman, Pilar)
August 27, 2018 Filing 69 NOTICE of Subpoena Duces Tecum to Jill M. Spoerke by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit A, #2 Certificate of Service)(Kraman, Pilar)
August 27, 2018 Filing 68 NOTICE of Subpoena Duces Tecum to Rohan V. Mendonca by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit A, #2 Certificate of Service)(Kraman, Pilar)
August 27, 2018 Filing 67 NOTICE of Subpoena Duces Tecum to Lee A. Honigberg by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit A, #2 Certificate of Service)(Kraman, Pilar)
August 20, 2018 Filing 66 REPLY BRIEF re #56 MOTION For Leave to Amend Answer, Affirmative Defenses, and Counterclaims and Joint Additional Parties, filed by Acerta Pharma B.V., Acerta Pharma LLC, AstraZeneca Pharmaceuticals LP. (Kraman, Pilar) Modified on 9/6/2018 (nms).
August 17, 2018 Filing 65 NOTICE of Subpoenas by AstraZeneca Pharmaceuticals LP (Attachments: #1 Exhibit A-Subpoena to Stacie A. Dalrymple, #2 Exhibit B-Subpoena to Shyr-Jiann Li, #3 Exhibit C-Subpoena to Paul A. Sprengeler)(Poff, Adam)
August 6, 2018 Filing 64 DECLARATION of G. Sobolski re #63 Answering Brief in Opposition, by Pharmacyclics LLC. (Attachments: #1 Exhibits)(Tigan, Jeremy) Modified on 9/6/2018 (nms).
August 6, 2018 Filing 63 ANSWERING BRIEF in Opposition re #56 MOTION For Leave to Amend Answer, Affirmative Defenses, and Counterclaims and Joint Additional Parties, filed by Pharmacyclics LLC. Reply Brief due date per Local Rules is 8/13/2018. (Tigan, Jeremy) Modified on 9/6/2018 (nms).
August 3, 2018 Opinion or Order Filing 62 ORDER approving #61 STIPULATION and Proposed Order Extending Time. Signed by Judge Eduardo C. Robreno on 8/3/2018. (nmf) Modified on 9/6/2018 (nms).
August 2, 2018 Filing 61 STIPULATION TO EXTEND TIME for Defendants to file a reply brief in support of their Motion to Amend to August 20, 2018 - filed by Pharmacyclics LLC. (Tigan, Jeremy)
July 27, 2018 Filing 60 REPLY BRIEF re #49 MOTION to Consolidate Cases filed by Acerta Pharma B.V., Acerta Pharma LLC, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit A through C, #2 Certificate of Service)(Kraman, Pilar)
July 18, 2018 Opinion or Order Filing 59 ORDER approving #58 STIPULATION TO EXTEND TIME 1) in C.A. 17-1582-ER for Plaintiff Pharmacyclics to respond to Defendants Motion to Amend [D.I. 56]; and (2) the deadlines in both C.A. 17-1582-ER and C.A. 18-581-ER for AstraZeneca and Acerta to file a reply brief in support, ORDER re-setting briefing schedule re #56 MOTION to Amend/Correct #12 Answer to Complaint, Counterclaim and Join Additional Parties : (Answering Brief due 8/6/2018.) ; re #49 MOTION to Consolidate Cases: (Reply Brief due 7/27/2018.) Signed by Judge Eduardo C. Robreno on 7/18/2018. (nmf)
July 18, 2018 Filing 58 STIPULATION and Proposed Order to Extend Time - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam) Modified on 9/6/2018 (nms).
July 16, 2018 Filing 57 OPENING BRIEF in Support re #56 MOTION For Leave to Amend Answer, Affirmative Defenses, and Counterclaims and Joint Additional Parties, filed by Acerta Pharma B.V., Acerta Pharma LLC, AstraZeneca Pharmaceuticals LP.Answering Brief/Response due date per Local Rules is 7/30/2018. (Attachments: #1 Amended Answer, #2 Exhibit B, #3 Exhibit C, #4 Certificate of Service)(Poff, Adam) Modified on 9/6/2018 (nms).
July 16, 2018 Filing 56 MOTION For Leave to Amend Answer, Affirmative Defenses, and Counterclaims and Joint Additional Parties - filed by Acerta Pharma B.V., Acerta Pharma LLC, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Proposed Order, #2 Certificate of Service)(Poff, Adam) Modified on 9/6/2018 (nms).
July 13, 2018 Filing 55 ANSWERING BRIEF in Opposition re #49 MOTION to Consolidate Cases filed by Pharmacyclics LLC.Reply Brief due date per Local Rules is 7/20/2018. (Attachments: #1 Exhibits A-B)(Tigan, Jeremy)
July 10, 2018 Opinion or Order Filing 54 ORDER approving #52 STIPULATION TO EXTEND TIME. Reset Briefing Schedule: The deadline for defendants to serve their initial invalidity contentions is extended through and including 7/6/2018. Deadline for plaintiff to respond to #49 MOTION to Consolidate Cases is extended through and including 7/13/2018. Signed by Judge Eduardo C. Robreno on 7/10/2018. (crb)
July 9, 2018 Case Reassigned to Judge Eduardo C. Robreno of the Eastern District of Pennsylvania (in lieu of Vacant Judgeship). Please include the initials of the Judge (ER) after the case number on all documents filed. Associated Cases: 1:17-cv-01582-ER, 1:18-cv-00581-ER (rjb)
July 6, 2018 Filing 53 NOTICE OF SERVICE of Defendants Initial Invalidity Contentions filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam)
July 2, 2018 Filing 52 STIPULATION TO EXTEND TIME for defendant to serve their initial invalidity contentions and for plaintiff to respond to defendants' Motion to Consolidate to July 6, 2018 and July 13, 2018, respectively - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam)
June 18, 2018 Opinion or Order SO ORDERED re (51 in 17-cv-1582-VAC-MPT, 14 in 18-cv-581-VAC-MPT) STIPULATION and Proposed Order to Extend Time. Signed by Judge Mary Pat Thynge on 6/18/18. Associated Cases: 1:18-cv-00581-VAC-MPT, 1:17-cv-01582-VAC-MPT(cak) Modified on 9/6/2018 (nms).
June 14, 2018 Filing 51 STIPULATION and Proposed Order to Extend Time - filed by AbbVie Inc., Pharmacyclics LLC. (Tigan, Jeremy) Modified on 9/6/2018 (nms).
June 12, 2018 Filing 50 OPENING BRIEF in Support re #49 MOTION to Consolidate Cases filed by Acerta Pharma B.V., Acerta Pharma LLC, AstraZeneca Pharmaceuticals LP.Answering Brief/Response due date per Local Rules is 6/26/2018. (Poff, Adam)
June 12, 2018 Filing 49 MOTION to Consolidate Cases - filed by Acerta Pharma B.V., Acerta Pharma LLC, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Rule 7.1.1 Certification, #2 Text of Proposed Order, #3 Certificate of Service)Motions referred to Mary Pat Thynge.(Poff, Adam)
June 1, 2018 Filing 48 NOTICE OF SERVICE of Pharmacyclics LLC's Infringement Contentions filed by Pharmacyclics LLC.(Tigan, Jeremy)
May 17, 2018 Filing 47 NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's First Set of Requests for Production (Nos. 1-106) filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam)
May 10, 2018 Filing 46 NOTICE OF SERVICE of Pharmacyclics LLC's Responses and Objections to Defendant AstraZeneca Pharmaceuticals LP's First Requests for Production of Documents (Nos. 1-132) filed by Pharmacyclics LLC.(Tigan, Jeremy)
April 19, 2018 Opinion or Order Filing 45 SO ORDERED re #44 Stipulated Protective Order. Signed by Judge Mary Pat Thynge on 4/19/18. (cak)
April 18, 2018 Filing 44 PROPOSED Protective Order, by Pharmacyclics LLC. (Tigan, Jeremy) Modified on 9/6/2018 (nms).
April 17, 2018 Opinion or Order SO ORDERED re #43 STIPULATION TO EXTEND TIME for the parties to file a Proposed Protective Order to April 18, 2018 filed by Pharmacyclics LLC. So Ordered by Judge Mary Pat Thynge on 4/17/18. (cak)
April 16, 2018 Filing 43 STIPULATION TO EXTEND TIME for the parties to file a Proposed Protective Order to April 18, 2018 - filed by Pharmacyclics LLC. (Tigan, Jeremy)
April 10, 2018 Filing 42 NOTICE OF SERVICE of Pharmacyclics LLC's First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-106) filed by Pharmacyclics LLC.(Tigan, Jeremy)
April 10, 2018 Opinion or Order Filing 41 ORDER re #38 Granting STIPULATION TO EXTEND TIME by which the parties may file a Proposed Protective Order to April 16, 2018 filed by Pharmacyclics LLC. Signed by Judge Mary Pat Thynge on 4/10/18. (kjk)
April 9, 2018 Filing 40 NOTICE OF SERVICE of Pharmacyclics LLC's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Pharmacyclics LLC.(Tigan, Jeremy)
April 9, 2018 Filing 39 NOTICE OF SERVICE of Defendants [Joint] Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam)
April 5, 2018 Filing 38 STIPULATION TO EXTEND TIME by which the parties may file a Proposed Protective Order to April 16, 2018 - filed by Pharmacyclics LLC. (Tigan, Jeremy)
April 3, 2018 Filing 37 NOTICE OF SERVICE of Defendant AstraZeneca Pharmaceuticals LPs First Requests for Production of Documents (Nos. 1-132) filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam)
April 2, 2018 Filing 36 NOTICE OF SERVICE of Pharmacyclics LLC's Initial Disclosures Identifying Defendants' Accused Products and Plaintiff's Asserted Patents filed by Pharmacyclics LLC.(Tigan, Jeremy)
April 2, 2018 Filing 35 STIPULATION TO EXTEND TIME for the parties to serve Paragraph 3 Disclosures to April 9, 2018 - filed by AstraZeneca Pharmaceuticals LP. (Kraman, Pilar)
April 2, 2018 Opinion or Order SO ORDERED re #35 STIPULATION TO EXTEND TIME for the parties to serve Paragraph 3 Disclosures to April 9, 2018 filed by AstraZeneca Pharmaceuticals LP. Signed by Judge Mary Pat Thynge on 4/2/18. (cak)
April 2, 2018 Opinion or Order SO ORDERED re #34 STIPULATION TO EXTEND TIME for the parties to file a Proposed Protective Order to April 9, 2018 filed by Pharmacyclics LLC. Signed by Judge Mary Pat Thynge on 4/2/18. (cak)
March 29, 2018 Filing 34 STIPULATION TO EXTEND TIME for the parties to file a Proposed Protective Order to April 9, 2018 - filed by Pharmacyclics LLC. (Tigan, Jeremy)
March 20, 2018 Opinion or Order SO ORDERED re #33 STIPULATION TO EXTEND TIME by which the parties may file a Proposed Protective Order to April 2, 2018 filed by Pharmacyclics LLC. Signed by Judge Mary Pat Thynge on 3/20/18. (cak)
March 19, 2018 Filing 33 STIPULATION TO EXTEND TIME by which the parties may file a Proposed Protective Order to April 2, 2018 - filed by Pharmacyclics LLC. (Tigan, Jeremy)
March 15, 2018 Filing 32 NOTICE OF SERVICE of Defendants Acerta Pharma B.V. and Acerta Pharma LLC's Initial Disclosures filed by Acerta Pharma B.V., Acerta Pharma LLC.(Dudash, Amy)
March 15, 2018 Filing 31 NOTICE OF SERVICE of Pharmacyclics LLC's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Pharmacyclics LLC.(Tigan, Jeremy)
March 15, 2018 Filing 30 NOTICE OF SERVICE of Defendant AstraZeneca's Initial Disclosures filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam)
March 8, 2018 Opinion or Order Filing 29 SCHEDULING ORDER: Joinder of Parties due by 7/16/2018. Fact Discovery completed by 6/12/2019. Opening Expert Reports due by 7/17/2019. Rebuttal Expert Reports due by 8/28/2019. Expert Discovery due by 10/25/2019. A Status Conference is set for 11/1/2018 at 11:00 AM before Judge Mary Pat Thynge Status Report due by 10/17/2018. Dispositive Motions due by 11/8/2019. Answering Brief due 12/6/2019. Reply Brief due 12/20/2019. Claim Construction Opening Brief due by 2/20/2019. Claim Construction Answering Brief due by 3/13/2019. Claim Construction Reply Brief due by 3/27/2019. Claim Construction Surreply Brief due by 4/10/2019. A Markman Hearing is set for 5/8/2019 at 9:00 AM before Judge Mary Pat Thynge. Proposed Pretrial Order due by 5/21/2020. A Final Pretrial Conference is set for 6/2/2020 at 09:00 AM before Vacant Judgeship (2017). A Jury Trial is set for 6/15/2020 at 09:30 AM before Vacant Judgeship (2017). Signed by Judge Mary Pat Thynge on 3/8/18. (cak)
March 8, 2018 Filing 28 NOTICE requesting Clerk to remove Jessica S. Richard as co-counsel. Reason for request: no longer associated with Williams & Connolly LLP. (Poff, Adam)
March 6, 2018 CORRECTING ENTRY: DI 28 deleted from the docket and added as an exhibit to DI 27 (cak)
March 5, 2018 Filing 27 PROPOSED ORDER // Scheduling Order by Pharmacyclics LLC. (Tigan, Jeremy) (Additional attachment(s) added on 3/6/2018: #1 Table of Proposed Dates) (cak).
March 1, 2018 Filing 26 NOTICE requesting Clerk to remove Raymond N. Nimrod, Matthew A. Traupman, Stephen A. Swedlow, and Amanda K. Antons, Ph.D. as co-counsel.. (Tigan, Jeremy)
February 23, 2018 Minute Entry for proceedings held before Judge Mary Pat Thynge - Telephone Conference re: Rule 16 Scheduling held on 2/23/2018; Counsel shall file a final scheduling order; ATTENDEES: - PLTFF. - J. Tigan, Esq.; M. Moran, Esq.; DEFT. - A. Dudash, Esq.; J. Gorman, Esq,; O. Bernson, Esq.; A. Poff, Esq.; D. Berl, Esq.; (Court Reporter V. Gunning.) (kjk)
February 16, 2018 Filing 25 PROPOSED ORDER // Scheduling Order re 24 Order Setting Teleconference, by Pharmacyclics LLC. (Tigan, Jeremy)
February 7, 2018 Opinion or Order Filing 24 ORAL ORDER Setting Rule 16 Scheduling Teleconference: Plaintiff's counsel to initiate the call. The Rule 16 Scheduling Telephone Conference set for 2/13/18 at 1:00 PM Eastern Time with Judge Thynge has been rescheduled to 2/23/2018 at 1:00 PM Eastern Time. The Proposed Scheduling Order shall now be due on or before 2/16/18. Ordered by Judge Mary Pat Thynge on 2/7/18. (cak)
January 30, 2018 Filing 23 ANSWER to #12 Answer to Complaint, Counterclaim /Answer to Defendant AstraZeneca Pharmaceuticals LP's Counterclaims by Pharmacyclics LLC.(Tigan, Jeremy)
January 26, 2018 Pro Hac Vice Attorney Gregory K. Sobolski for Pharmacyclics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
January 25, 2018 Opinion or Order Filing 22 ORAL ORDER Setting Teleconference: The Rule 16 scheduling teleconference with Judge Thynge, set for 1/29/18 at 2:00 PM Eastern Time and proposed scheduling order due date of 1/25/18, has been rescheduled to 2/13/2018 at 1:00 PM Eastern Time. The proposed scheduling order shall now be due on or before 2/8/18. Plaintiff's counsel shall initiate the teleconference call. Ordered by Judge Mary Pat Thynge on 1/25/18. (cak)
January 22, 2018 Pro Hac Vice Attorney Olga Berson for Acerta Pharma B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
January 19, 2018 Filing 21 MOTION for Pro Hac Vice Appearance of Attorney Lesley M. Hamming - filed by Pharmacyclics LLC. Motions referred to Mary Pat Thynge.(Tigan, Jeremy)
January 19, 2018 Opinion or Order SO ORDERED granting #20 Motion to Appear Pro Hac Vice of Attorney Michael A. Morin, David P. Frazier, Brenda L. Danek, Gregory K. Sobolski, Lauren K. Sharkey, and Kamilah Alexander - filed by Pharmacyclics LLC. Signed by Judge Mary Pat Thynge on 1/19/18. (cak)
January 19, 2018 Opinion or Order SO ORDERED granting #21 Motion to Appear Pro Hac Vice of Lesley M. Hamming to represent plaintiff Pharmacyclics LLC. Signed by Judge Mary Pat Thynge on 1/19/18. (cak)
January 18, 2018 Filing 20 MOTION for Pro Hac Vice Appearance of Attorney Michael A. Morin, David P. Frazier, Brenda L. Danek, Gregory K. Sobolski, Lauren K. Sharkey, and Kamilah Alexander - filed by Pharmacyclics LLC. Motions referred to Mary Pat Thynge.(Tigan, Jeremy)
January 18, 2018 Opinion or Order Filing 19 Order Setting Telephonic Scheduling Conference: A Rule 16 Scheduling Teleconference is set for 1/29/2018 at 3:00 PM Eastern Time before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 1/18/18. (cak)
January 16, 2018 Pro Hac Vice Attorney John V. Gorman for Acerta Pharma B.V.,Acerta Pharma LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
January 16, 2018 Pro Hac Vice Attorney Dov P. Grossman for AstraZeneca Pharmaceuticals LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
January 12, 2018 Filing 18 MOTION for Pro Hac Vice Appearance of Attorney John V. Gorman, Eric Kraeutler, and Olga Berson, Ph.D. - filed by Acerta Pharma B.V., Acerta Pharma LLC. Motions referred to Mary Pat Thynge.(Marston, David)
January 12, 2018 Opinion or Order SO ORDERED granting #18 Motion to Appear Pro Hac Vice of Attorney John V. Gorman, Eric Kraeutler, and Olga Berson, Ph.D. - filed by Acerta Pharma B.V., Acerta Pharma LLC. Signed by Judge Mary Pat Thynge on 1/12/18. (cak)
January 10, 2018 Pro Hac Vice Attorney Kevin D. Hoagland-Hanson for AstraZeneca Pharmaceuticals LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (nmg)
January 10, 2018 Opinion or Order SO ORDERED granting #16 Motion to Appear Pro Hac Vice of Attorney Dov P. Grossman, Jessica S. Richard, Kevin D. Hoagland-Hanson, and Galina I. Fomenkova - filed by AstraZeneca Pharmaceuticals LP. Signed by Judge Mary Pat Thynge on 1/10/18. (cak)
January 9, 2018 Filing 17 NOTICE of Entry of Appearance of Teagan Gregory, Esquire of Williams & Connolly LLP as additional counsel for defendant, AstraZeneca Pharmaceuticals LP by AstraZeneca Pharmaceuticals LP (Poff, Adam)
January 9, 2018 Filing 16 MOTION for Pro Hac Vice Appearance of Attorney Dov P. Grossman, Jessica S. Richard, Kevin D. Hoagland-Hanson, and Galina I. Fomenkova - filed by AstraZeneca Pharmaceuticals LP. Motions referred to Mary Pat Thynge.(Poff, Adam)
January 9, 2018 Filing 15 NOTICE of Appearance by Amy Michele Dudash on behalf of Acerta Pharma B.V., Acerta Pharma LLC (Dudash, Amy)
January 9, 2018 Filing 14 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Acerta Pharma B.V., Acerta Pharma LLC filed by Acerta Pharma B.V., Acerta Pharma LLC. (nmg)
January 9, 2018 Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC, for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam)
January 9, 2018 Filing 12 Joint ANSWER to #1 Complaint, with Jury Demand of all Defendants, COUNTERCLAIM against Pharmacyclics LLC by AstraZeneca Pharmaceuticals LP.(Poff, Adam)
December 12, 2017 Pro Hac Vice Attorney Stanley E. Fisher for AstraZeneca Pharmaceuticals LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
December 8, 2017 Pro Hac Vice Attorney David I. Berl for AstraZeneca Pharmaceuticals LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
December 6, 2017 Filing 11 MOTION for Pro Hac Vice Appearance of Attorney David I. Berl and Attorney Stanley E. Fisher - filed by AstraZeneca Pharmaceuticals LP. Motions referred to Mary Pat Thynge.(Poff, Adam)
December 6, 2017 Opinion or Order SO ORDERED granting #11 Motion to Appear Pro Hac Vice of Attorneys David I. Berl and Attorney Stanley E. Fisher - filed by AstraZeneca Pharmaceuticals LP. Signed by Judge Mary Pat Thynge on 12/6/17. (cak)
November 27, 2017 Filing 10 Joint STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to Plaintiff's Complaint to January 9, 2018 - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam)
November 27, 2017 Opinion or Order SO ORDERED re #10 Joint STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to Plaintiff's Complaint to January 9, 2018. Signed by Judge Mary Pat Thynge on 11/27/17. (cak)
November 27, 2017 Set/Reset Answer Deadlines: Answer for All Defendants now due 1/9/18. (cak)
November 9, 2017 Filing 9 SUMMONS Returned Executed by Pharmacyclics LLC. Acerta Pharma LLC served on 11/6/2017, answer due 11/27/2017. (Dellinger, Megan)
November 9, 2017 Filing 8 SUMMONS Returned Executed by Pharmacyclics LLC. Acerta Pharma B.V. served on 11/6/2017, answer due 11/27/2017. (Dellinger, Megan)
November 9, 2017 Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Raymond N. Nimrod - filed by Pharmacyclics LLC. Motions referred to Mary Pat Thynge.(Dellinger, Megan)
November 9, 2017 Opinion or Order SO ORDERED granting #7 Motion to Appear Pro Hac Vice of Attorney Raymond N. Nimrod - filed by Pharmacyclics LLC. Signed by Judge Mary Pat Thynge on 11/9/17. (cak)
November 8, 2017 Filing 6 MOTION for Pro Hac Vice Appearance of Attorney Matthew A. Traupman, Stephen A. Swedlow, and Amanda K. Antons, Ph.D. - filed by Pharmacyclics LLC. (Dellinger, Megan)
November 8, 2017 Opinion or Order SO ORDERED granting #6 Motion to Appear Pro Hac Vice of Attorney Matthew A. Traupman, Stephen A. Swedlow, and Amanda K. Antons, Ph.D. to represent plaintiff Pharmacyclics. Signed by Judge Mary Pat Thynge on 11/8/17. (cak)
November 8, 2017 CASE REFERRED to Magistrate Judge Mary Pat Thynge. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) Motions referred to Mary Pat Thynge.(rjb)
November 8, 2017 Case Assigned to Vacant Judgeship (2017). Please include initials of VAC after the case number on all documents filed. (rjb)
November 8, 2017 ***NOTE: If the parties jointly consent to Chief Magistrate Judge Thynges jurisdiction to conduct all proceedings in this case, then the Pretrial Conference and Trial will be presided over by Judge Thynge consistent with 28 U.S.C. 636. Otherwise, in accordance with the District Court's procedures for "Assignment of Cases to Visiting Judges" (issued May 26, 2017 and available on the District Court's website), upon the filing of a case-dispositive motion (e.g., a motion to dismiss, a motion for judgment on the pleadings, a motion for summary judgment, or initiation of the claim construction process in a patent case), VAC cases will be reassigned to a visiting District Judge, and any further dates in the Scheduling Order, including the Pretrial Conference and Trial dates, may be adjusted dependent on the availability of the visiting District Judge. (cak)
November 6, 2017 Filing 5 SUMMONS Returned Executed by Pharmacyclics LLC. AstraZeneca Pharmaceuticals LP served on 11/6/2017, answer due 11/27/2017. (Dellinger, Megan)
November 3, 2017 Filing 4 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Pharmacyclics LLC filed by Pharmacyclics LLC. (ceg)
November 3, 2017 Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,079,908 B2; 9,139,591 B2; 9,556,182 B2. (ceg)
November 3, 2017 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg)
November 3, 2017 Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Acerta Pharma B.V., Acerta Pharma LLC, AstraZeneca Pharmaceuticals LP - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2259696.) - filed by Pharmacyclics LLC. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet)(ceg)
November 3, 2017 Summons Issued with Magistrate Consent Notice attached as to Acerta Pharma B.V. on 11/3/2017; Acerta Pharma LLC on 11/3/2017; AstraZeneca Pharmaceuticals LP on 11/3/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Pharmacyclics LLC v. Acerta Pharma B.V. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Acerta Pharma LLC
Represented By: John V. Gorman
Represented By: Amy Michele Dudash
Represented By: David W. Marston, Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Acerta Pharma B.V.
Represented By: John V. Gorman
Represented By: Olga Berson
Represented By: Amy Michele Dudash
Represented By: David W. Marston, Jr.
Represented By: Robert Smyth
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: AstraZeneca Pharmaceuticals LP
Represented By: Stanley E. Fisher
Represented By: Adam Wyatt Poff
Represented By: Kevin D. Hoagland-Hanson
Represented By: Dov P. Grossman
Represented By: David I. Berl
Represented By: Pilar Gabrielle Kraman
Represented By: James Kirkpatrick
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Pharmacyclics LLC
Represented By: Rodger Dallery Smith, II
Represented By: Mary B. Graham
Represented By: Megan Elizabeth Dellinger
Represented By: Jeremy A. Tigan
Represented By: Michael A. Morin
Represented By: Lauren Sharkey
Represented By: Lesley M. Hamming
Represented By: Brenda L. Danek
Represented By: Gregory K. Sobolski
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?